Status | Study |
RECRUITING |
Study Name: Phase 1 Study to Assess Safety and Efficacy of ANG003 Condition: Exocrine Pancreatic Insufficiency Date: 2023-08-09 Interventions: To evaluate four possible combinations of lipase, protease and amylase. |
RECRUITING |
Study Name: Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis Condition: Exocrine Pancreatic Insufficiency Date: 2023-01-31 Interventions: Enteric microgranule formulation of adrulipase. |
Recruiting |
Study Name: Pancreatic Exocrine Insufficiency in Acute Pancreatitis Condition: Exocrine Pancreatic Insufficiency Acute Pancreatitis Date: 2015-09-27 |
Completed |
Study Name: Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Condition: Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Date: 2015-03-19 Interventions: Drug: Creon IR Drug: Creon® (DR/GR) |
Completed |
Study Name: A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI Condition: Diabetes Mellitus, Type 2 Exocrine Pancreatic Insufficiency Date: 2015-02-24 Interventions: Drug: Epanova® (omega-3 carboxylic acids) |
Withdrawn |
Study Name: A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2 Condition: Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Date: 2013-11-25 Interventions: Drug: Creon Creon 25000 (2 cap |
Completed |
Study Name: Pancreatic Insufficiency Secondary to Tobacco Exposure Condition: Pancreatic Insufficiency Date: 2013-07-24 |
Completed |
Study Name: Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency Condition: Pancreatic Exocrine Insufficiency Date: 2012-11-23 Interventions: Drug: Pancreatin Doses of Pancreatin <2500 lipase u/kg/feed or <4000 lipase U/g fat/intake or < |
Completed |
Study Name: Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis. Condition: Exocrine Pancreatic Insufficiency: Cystic Fibrosis Date: 2012-07-10 Interventions: Drug: EUR-1008 25,000 Units EU |
Completed |
Study Name: Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency Condition: Exocrine Pancreatic Insufficiency Cystic Fibrosis Date: 2011-03-28 Interventions: Drug: Panzytrat® 25,000 P |